Yanick J. Crow has been chosen for the 2024 ICIS-Pfizer Award for Excellence in Cytokine & Interferon Research
Awards

Yanick J. Crow has been chosen for the 2024 ICIS-Pfizer Award for Excellence in Cytokine & Interferon Research

Yanick J. Crow has been selected as the 2024 ICIS-Pfizer Award for Excellence in Interferon and Cytokine Research in recognition for his groundbreaking research on Type I Interferonopathies which has revolutionized the fields of basic and clinical immunology with phenomenal clinical and biological implications. Professor Crow is recognized as one of the top three scientists in the field of human inborn errors of immunity and the founder of the rapidly growing and revolutionary field of “Type I interferonopathies,” making him a most deserving recipient for the ICIS-Pfizer Award for Excellence in Cytokine & Interferon Research. [READ MORE]

Stefan Rose-John is recognized as the 2024 ICIS-BioLegend William E. Paul Award
Awards

Stefan Rose-John is recognized as the 2024 ICIS-BioLegend William E. Paul Award

Stefan Rose-John is recognized as the 2024 ICIS-BioLegend William E. Paul Award winner in recognition for his seminal contributions to the field of cytokine biology. With a primary focus on the IL-6 cytokine family, his fundamental research has pioneered several paradigm-shifting discoveries, which have steered understanding of IL-6 in physiology and pathophysiology. Moreover, these insights have informed refinements affecting how target IL-6 for therapy. By presenting this Award, which is generously sponsored by BioLegend, the ICIS recognizes Professor Rose-John as one of a rare breed of scientists who has excelled in discovery science, achieved success as an entrepreneur, and translated his basic scientific discoveries into treatments that directly ameliorate patients’ lives. [READ MORE]

Laura Mackay Awarded the 2024 ICIS-Luminex John R. Kettman Award for Excellence in Cytokine & Interferon Research Mid-Career
Awards

Laura Mackay Awarded the 2024 ICIS-Luminex John R. Kettman Award for Excellence in Cytokine & Interferon Research Mid-Career

Laura Mackay has been selected as the 2024 ICIS-Luminex John R. Kettman Award for Excellence in Cytokine & Interferon Research in recognition for her outstanding work on memory T cell populations and the cytokines that control them. Professor Mackay’s discoveries have resulted in dramatic paradigm shifts and have contributed enormously to the T cell field, spawning a new focus on tissue immunity. Her accomplishments are shaping and redefining how we understand cellular immune responses and have driven a new field of T cell immunology. These accomplishments indeed far exceed her designated “mid-career” stage. [READ MORE]

2024 ICIS Young Investigator Award Nominations/Applications - Due April 3, 2024
Awards

2024 ICIS Young Investigator Award Nominations/Applications due April 3rd

Candidates may apply or be nominated for MORE THAN ONE YOUNG INVESTIGATOR AWARD using the Nomination/Application Form below as well as for a Cytokines 2024 Travel Award (applied for via the Cytokines 2024 Abstract Submission), but will not be awarded more than one award in a given year. Deadline for submitting Young Investigator award application is extended to Wednesday, 3 April, 2024.

Nominations by mentors and/or colleagues for the Young Investigator Awards or self-applicants, please use one form for each candidate for ALL 2024 Young Investigator Award nominations or applications. Candidates may be nominated for more than one award using the same form (multi-select), but please use a separate form for each candidate. [READ MORE]

Cytokines 2024 / KAI 2024 Awards
Awards

ICIS Senior & Mid-Career Awards Nomination Deadline is March 4th – Recognizing Excellence in Cytokine Biology

ICIS Council is proud of the high level of award winners at every career stage, and it is a source of satisfaction that the Awards Committee has to choose between so many inspiring candidates. Consider the careers and contributions to our field that past ICIS award winners have and continue to make and it is clear how important it is that we recognize those who are revolutionizing modern medicine and leading to new treatments in autoimmune diseases, cancer and infectious diseases. [READ MORE]